Cargando…
Combination of Panax ginseng C. A. Mey and Febuxostat Boasted Cardioprotective Effects Against Doxorubicin-Induced Acute Cardiotoxicity in Rats
Doxorubicin (DOX) is an anticancer agent for treating solid and soft tissue malignancies. However, the clinical use of DOX is restricted by cumulative, dose-dependent cardiotoxicity. Therefore, the present study aimed to assess the cardioprotective effects of P. ginseng C. A. Mey, febuxostat, and th...
Autores principales: | Al-Kuraishy, Hayder M., Al-Hussaniy, Hany A., Al-Gareeb, Ali I., Negm, Walaa A., El-Kadem, Aya H., Batiha, Gaber El-Saber, N. Welson, Nermeen, Mostafa-Hedeab, Gomaa, Qasem, Ahmed H, Conte-Junior, Carlos Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257079/ https://www.ncbi.nlm.nih.gov/pubmed/35814241 http://dx.doi.org/10.3389/fphar.2022.905828 |
Ejemplares similares
-
Selinexor and COVID-19: The Neglected Warden
por: Mostafa-Hedeab, Gomaa, et al.
Publicado: (2022) -
Trimetazidine and COVID-19-induced acute cardiac injury: a missed key
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Pathophysiology of Post-COVID syndromes: a new perspective
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022) -
Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon
por: Al-kuraishy, Hayder M., et al.
Publicado: (2023) -
A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19
por: Mostafa-Hedeab, Gomaa, et al.
Publicado: (2022)